Placenta-specific protein 1 (PLAC1) expression in serous ovarian cancer is significantly determined by p53 mutation status
Publication
, Conference
Miller, MD; Devor, E; Warrier, A; Reyes, HD; Schickling, BM; Goodheart, MJ; Leslie, KK; Gonzalez Bosquet, J
Published in: Gynecologic Oncology
June 2017
Duke Scholars
Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
June 2017
Volume
145
Start / End Page
104 / 104
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Miller, M. D., Devor, E., Warrier, A., Reyes, H. D., Schickling, B. M., Goodheart, M. J., … Gonzalez Bosquet, J. (2017). Placenta-specific protein 1 (PLAC1) expression in serous ovarian cancer is significantly determined by p53 mutation status. In Gynecologic Oncology (Vol. 145, pp. 104–104). Elsevier BV. https://doi.org/10.1016/j.ygyno.2017.03.245
Miller, M. D., E. Devor, A. Warrier, H. D. Reyes, B. M. Schickling, M. J. Goodheart, K. K. Leslie, and J. Gonzalez Bosquet. “Placenta-specific protein 1 (PLAC1) expression in serous ovarian cancer is significantly determined by p53 mutation status.” In Gynecologic Oncology, 145:104–104. Elsevier BV, 2017. https://doi.org/10.1016/j.ygyno.2017.03.245.
Miller MD, Devor E, Warrier A, Reyes HD, Schickling BM, Goodheart MJ, et al. Placenta-specific protein 1 (PLAC1) expression in serous ovarian cancer is significantly determined by p53 mutation status. In: Gynecologic Oncology. Elsevier BV; 2017. p. 104–104.
Miller, M. D., et al. “Placenta-specific protein 1 (PLAC1) expression in serous ovarian cancer is significantly determined by p53 mutation status.” Gynecologic Oncology, vol. 145, Elsevier BV, 2017, pp. 104–104. Crossref, doi:10.1016/j.ygyno.2017.03.245.
Miller MD, Devor E, Warrier A, Reyes HD, Schickling BM, Goodheart MJ, Leslie KK, Gonzalez Bosquet J. Placenta-specific protein 1 (PLAC1) expression in serous ovarian cancer is significantly determined by p53 mutation status. Gynecologic Oncology. Elsevier BV; 2017. p. 104–104.
Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
June 2017
Volume
145
Start / End Page
104 / 104
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis